Rebecca Halperin
Postdoctoral Fellow (previously held)
Boston University Chobanian & Avedisian School of Medicine



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Raupach EA, Hegde AM, Garcia-Mansfield K, Alcantara M, Rose DL, Halperin RF, Orlando KA, Lang JD, Sharma R, David-Dirgo V, Facista SJ, Moore R, Kofman R, Jensen ZN, Zismann VL, Karnezis AN, Wang Y, Bennett LB, Whitsett TG, Kortylewski M, Hendricks WPD, Huntsman DG, Rodriguez-Rodriguez L, Weissman BE, Trent JM, Pirrotte P. Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type. Cancer Res. 2025 Jul 15; 85(14):2626-2642. PMID: 40407709; PMCID: PMC12260517; DOI: 10.1158/0008-5472.CAN-24-0044;
     
  2. Sholler GLS, Bergendahl G, Lewis EC, Kraveka J, Ferguson W, Nagulapally AB, Dykema K, Brown VI, Isakoff MS, Junewick J, Mitchell D, Rawwas J, Roberts W, Eslin D, Oesterheld J, Wada RK, Pastakia D, Harrod V, Ginn K, Saab R, Bielamowicz K, Glover J, Chang E, Hanna GK, Enriquez D, Izatt T, Halperin RF, Moore A, Byron SA, Hendricks WPD, Trent JM. Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial. Genome Med. 2024 Feb 12; 16(1):28. PMID: 38347552; PMCID: PMC10860258; DOI: 10.1186/s13073-024-01297-5;
     
  3. Anker J, Pal SK, Kim-Schulze S, Wang H, Halperin R, Uzilov A, Imai N, Eikawa S, Saito T, Sebra R, Hahn NM, Patel M, Qi J, Xie H, Bhardwaj N, Gnjatic S, Galsky MD. Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer. J Immunother Cancer. 2023 Aug; 11(8). PMID: 37607770; PMCID: PMC10445357; DOI: 10.1136/jitc-2023-007613;
     
  4. Levy I, Levin EG, Olmer L, Regev-Yochay G, Agmon-Levin N, Wieder-Finesod A, Indenbaum V, Herzog K, Doolman R, Asraf K, Halperin R, Lustig Y, Rahav G. Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine. Vaccines (Basel). 2022 Jul 30; 10(8). PMID: 36016109
     
  5. Wong S, Ehrhart EJ, Stewart S, Zismann V, Cawley J, Halperin R, Briones N, Richter K, Sivaprakasam K, Perdigones N, Contente-Cuomo T, Facista S, Trent JM, Murtaza M, Khanna C, Hendricks WPD. Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients. PLoS One. 2022; 17(7):e0264986. PMID: 35867969; PMCID: PMC9307279; DOI: 10.1371/journal.pone.0264986;
     
  6. Rahav G, Lustig Y, Lavee J, Ohad Benjamini, Magen H, Hod T, Noga Shem-Tov, Shmueli ES, Drorit Merkel, Ben-Ari Z, Halperin R, Indenbaum V, Olmer L, Huppert A, Mor E, Regev-Yochay G, Cohen C, Finesod AW, Levy I. BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study. EClinicalMedicine. 2021 Nov; 41:101158. PMID: 34693234
     
  7. Byron SA, Hendricks WPD, Nagulapally AB, Kraveka JM, Ferguson WS, Brown VI, Eslin DE, Mitchell D, Cornelius A, Roberts W, Isakoff MS, Oesterheld JE, Wada RK, Rawwas J, Neville K, Zage PE, Harrod VL, Bergendahl G, VanSickle E, Dykema K, Bond J, Chou HC, Wei JS, Wen X, Reardon HV, Roos A, Nasser S, Izatt T, Enriquez D, Hegde AM, Cisneros F, Christofferson A, Turner B, Szelinger S, Keats JJ, Halperin RF, Khan J, Saulnier Sholler GL, Trent JM. Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion. Cancer Res. 2021 12 01; 81(23):5818-5832. PMID: 34610968; PMCID: PMC10240575; DOI: 10.1158/0008-5472.CAN-21-1033;
     
  8. Halperin RF, Hegde A, Lang JD, Raupach EA, Legendre C, Liang WS, LoRusso PM, Sekulic A, Sosman JA, Trent JM, Rangasamy S, Pirrotte P, Schork NJ. Improved methods for RNAseq-based alternative splicing analysis. Sci Rep. 2021 05 24; 11(1):10740. PMID: 34031440; PMCID: PMC8144374; DOI: 10.1038/s41598-021-89938-2;
     
  9. LoRusso PM, Sekulic A, Sosman JA, Liang WS, Carpten J, Craig DW, Solit DB, Bryce AH, Kiefer JA, Aldrich J, Nasser S, Halperin R, Byron SA, Pilat MJ, Boerner SA, Durecki D, Hendricks WPD, Enriquez D, Izatt T, Keats J, Legendre C, Markovic SN, Weise A, Naveed F, Schmidt J, Basu GD, Sekar S, Adkins J, Tassone E, Sivaprakasam K, Zismann V, Calvert VS, Petricoin EF, Fecher LA, Lao C, Eder JP, Vogelzang NJ, Perlmutter J, Gorman M, Manica B, Fox L, Schork N, Zelterman D, DeVeaux M, Joseph RW, Cowey CL, Trent JM. Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial. PLoS One. 2021; 16(4):e0248097. PMID: 33826614; PMCID: PMC8026051; DOI: 10.1371/journal.pone.0248097;
     
  10. Blomquist MR, Ensign SF, D'Angelo F, Phillips JJ, Ceccarelli M, Peng S, Halperin RF, Caruso FP, Garofano L, Byron SA, Liang WS, Craig DW, Carpten JD, Prados MD, Trent JM, Berens ME, Iavarone A, Dhruv H, Tran NL. Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa078. PMID: 32743548; PMCID: PMC7388612; DOI: 10.1093/noajnl/vdaa078;
     
Showing 10 of 29 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 29 publications over 13 distinct years, with a maximum of 4 publications in 2017 and 2021

YearPublications
20063
20073
20083
20101
20122
20174
20193
20201
20214
20222
20231
20241
20251

Contact for Mentoring:

72 E. Concord St Housman (R)
Boston MA 02118
Google Map


Halperin's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Similar People
_